Journal Guide

Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world’s scientific community with special attention to the area of clinical oncology and the Asian region.JJCO publishes various articles types including:*Original Articles*Case Reports*Clinical Trial Notes*Cancer Genetics Reports*Epidemiology Notes*Technical Notes*Short Communications*Letters to the Editors*Solicited ReviewsThe journal also welcomes interim articles on the design and plan of phase studies before actual results are obtained. While clinical trials usually require a long time to accomplish a conclusive outcome, the journal believes reports of interim outcomes will be highly appreciated by its audience. .

Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.The journal welcomes submissions in the following areas and other related topics:Basic Tumor ImmunologyTumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune responseClinical/Translational Cancer ImmunotherapyFirst-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcomeImmunotherapy BiomarkersPredictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studiesReviews/EditorialsTriggering discussion on hot topics and innovative concepts

Journal for ImmunoTherapy of Cancer is the official journal of the Society for Immunotherapy of Cancer (SITC). The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit society of medical professionals that was established in 1984 to exchange, encourage and promote information about the promise and breakthroughs of biological therapies, including immunotherapy, for patients with cancer. SITC is the world's leading member society of medical professionals dedicated to advancing cancer immunotherapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field.

The 'Journal of Cancer Research and Clinical Oncology' publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers and Rapid communications (given priority treatment by the Editors), also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses. The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.

JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

Journal of Hematology & Oncology provides a forum for top-quality research in the fields of hematology and oncology.

The Journal of Immunotherapy publishes basic scientific and clinical studies of the immunologic response to tumors and other diseases. It addresses the latest advances in basic cytokine research (interferons, interleukins, and newly described factors); immune regulation; immune response to diseases and associated antigens; growth factors and their receptors; hematopoietic factors; monoclonal antibodies; therapeutic studies in animal models; immunotherapy research, including active immunization and adaptive immunotherapy in animal models and humans; and clinical trials. 160;.

Journal of Mammary Gland Biology and Neoplasia provides researchers within and outside the field of mammary gland biology with an integrated source of information derived from studies of the development, function, and pathology of the mammary gland. This quarterly journal offers comprehensive analyses of all aspects of the field, considering the fundamental biology and pathology of the mammary gland including, but not restricted to mammary development, the biology of breast cancer, lactation, milk proteins, bioactive agents in milk, hormonal regulation, growth factors, signal transduction, nutrition, and genetics. Each outstanding issue, guest edited by prominent authorities in the field, contains a series of minireviews encompassing a single topic. Researchers in the field of mammary gland biology, dairy scientists, and breast cancer researchers, as well as cell biologists, medical scientists, oncologists, nutritionists, pediatricians, and obstetricians will benefit from this quarterly.

The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan literally dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.

The aim of the Journal of Oral Pathology & Medicine is to publish manuscripts of high scientific quality representing original clinical, diagnostic or experimental work in oral pathology and oral medicine. Papers advancing the science or practice of these disciplines will be welcomed, especially those which bring new knowledge and observations from the application of techniques within the spheres of light and electron microscopy, tissue and organ culture, immunology, histochemistry and immunocytochemistry, microbiology, genetics and biochemistry. Review papers on topical and relevant subjects will receive a high priority. Original research material requiring rapid publication because of their significance and timeliness will be included as Brief Reports. They should not exceed three pages. All submitted manuscripts falling within the overall scope of the Journal will be assessed by at least two suitably qualified referees. Rapid publication.

Journal of the Egyptian National Cancer Institute aims at publishing articles related to all fields of cancer in order to disperse up-to-date information to all medical personnel interested in this field.

Scope:

Journal of the Egyptian National Cancer Institute publishes original articles related to all fields of cancer, including basic, applied, and clinical cancer research.

The Journal of the National Cancer Institute (print ISSN: 0027-8874, online ISSN: 1460-2105) publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.JNCI is indexed and abstracted by the following:Abstracts on Hygiene and Communicable DiseasesAgbiotech News and InformationAmerican Statistics IndexAnnals of Behavioral MedicineAbstracts in AnthropologyBiological AbstractsBIOSIS PreviewsCAB AbstractsCINAHLCSA Oncogenes and Growth Factor AbstractsCurrent Contents® /Clinical MedicineCurrent Contents® /Life SciencesDairy Science AbstractsDerwent Drug FileElsevier BIOBASE - Current Awareness in Biological Sciences (CABS)Environmental Science and Pollution ManagementExcerpta Medica Abstract JournalsFood Science and Technology AbstractsGlobal HealthHealth & Safety Science AbstractsIDISINIS AtomindexInternational Pharmaceutical AbstractsJournal Citation Reports /Science EditionNutrition Abstracts and ReviewsNutrition Research NewsletterOncology information servicePharmacoeconomics and Outcome NewsPROQUEST DATABASE : MagazinesPROQUEST DATABASE : MEDLINE with Full TextPROQUEST DATABASE : ProQuest 5000PROQUEST DATABASE : ProQuest 5000 InternationalPROQUEST DATABASE : ProQuest Biology JournalsPROQUEST DATABASE : ProQuest CentralPROQUEST DATABASE : ProQuest DiscoveryPROQUEST DATABASE : ProQuest Family HealthPROQUEST DATABASE : ProQuest Health & Medical CompletePROQUEST DATABASE : ProQuest International Academic Research LibraryPROQUEST DATABASE : ProQuest Medical LibraryPROQUEST DATABASE : ProQuest News & MagazinesPROQUEST DATABASE : ProQuest Nursing & Allied Health SourcePROQUEST DATABASE : ProQuest Pharma CollectionPROQUEST DATABASE : ProQuest PlatinumPROQUEST DATABASE : ProQuest Research LibraryPubMedProus Science Integrity®Reactions WeeklyReview of Aromatic and Medicinal PlantsReview of Medical and Veterinary MycologyRisk AbstractsRural Development AbstractsSage Race Relations AbstractsScience Citation Index Expanded (SciSearch®)Science Citation Index®Soybean AbstractsThe Standard Periodical DirectoryToxicology AbstractsTropical Diseases BulletinWeed AbstractsJNCI is published twice monthly by Oxford University Press and is not affiliated with the United States National Cancer Institute. .

Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.Impact Factor2010 Impact Factor: 8.966*Rank:4/65 Hematology10/184 Oncology*2010 Journal Citation Reports (Thomson Reuters, 2011)Abstracted/indexed inBIOBASE/Current Awareness in Biological SciencesBIOSISCambridge Scientific AbstractsCurrent Advances in Cell and Developmental BiologyCurrent Advances in Genetics and Molecular BiologyCurrent ContentsCurrent Contents/Life SciencesEMBASE/Excerpta MedicaMEDLINE/Index MedicusResearch AlertReference UpdateScience Citation IndexScience Citation Index ExpandedSUBISISSN and eISSNThe international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.